0 CHECKOUT

PRODUCT FILTERS

REGION

56
54
54
51
51

COUNTRY

51
3
3
3
3

PRICE

2
14
31
117

PUBLISHED

26
28
77
117

PRODUCT TYPE

117

Ovarian Cancer

Far less common than breast cancer, but with a higher mortality rate, sufferers of ovarian cancer are experiencing significant unmet needs. There are therefore considerable market opportunities for drug designers and manufacturers in this life-saving sector of the pharmaceutical industry. In this section a host of cutting edge reports provide valuable insight into key markets such as China and the US, the latest drug development activities and the market trends (including sales, pricing and forecasts) for specific drugs like Doxil, Caelyx, Yondelis and Paclitaxel. You can also purchase reports that feature the latest strategies of major and niche industry players such as Alza Corporation, Amgen, Bristol-Myers Squibb, Cell Therapeutics, Genentech, GlaxoSmithKline, Immunogen, Ivax, OSI Pharmaceuticals and Raven Biotechnologies.
Show Less
Read more

Investigation Report on China's Paclitaxel Market, 2010-2019

When paclitaxel first came into the market, American Food and Drug Administration (FDA) only approved it to be used in the clinical treatment of advanced non-small cell cancer and advanced ovarian cancer....

Published:  June 2015
Price:  From

CAS Melphalan World Consumption Report

This CAS Melphalan World Consumption Report provides data on the net consumption of CAS 148-82-3 - Melphalan Substance(s) in each of the countries listed. The Substance(s) covered (Melphalan ) are classified...

Published:  February 2016
Price: 

CAS Altretamine World Consumption Report

This CAS Altretamine World Consumption Report provides data on the net consumption of CAS 645-05-6 - Altretamine Substance(s) in each of the countries listed. The Substance(s) covered (Altretamine )...

Published:  February 2016
Price: 

Gemcitabine - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent,...

Published:  February 2016
Price: 

CAS Cyclophosphamide World Consumption Report

This CAS Cyclophosphamide World Consumption Report provides data on the net consumption of CAS 50-18-0 - Cyclophosphamide Substance(s) in each of the countries listed. The Substance(s) covered (Cyclophosphamide...

Published:  February 2016
Price: 

CAS Methotrexate World Consumption Report

This CAS Methotrexate World Consumption Report provides data on the net consumption of CAS 59-05-2 - Methotrexate Substance(s) in each of the countries listed. The Substance(s) covered (Methotrexate...

Published:  February 2016
Price: 

Metastatic Ovarian Cancer-API Insights

Summary Metastatic Ovarian Cancer-API Insights, 2015 report provides Metastatic Ovarian Cancer drugs marketed details and API Manufacturers details across the globe along with the location. The report...

Published:  February 2016
Price:  From

Gemcitabine - Patent, Extension and Data Exclusivity Expiry Snapshot (51 countries)

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent,...

Published:  February 2016
Price: 

Gemzar-API Insights

Summary The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large...

Published:  February 2016
Price:  From

Ovarian Cancer-API Insights

Summary Ovarian Cancer-API Insights, 2015 report provides Ovarian Cancer drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear...

Published:  February 2016
Price:  From

Epithelial Ovarian Cancer-Pipeline Insights, 2016

“ Epithelial Ovarian Cancer-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Epithelial Ovarian Cancer. The report covers the product...

Published:  February 2016
Price:  From

Avastin -Drug Insights, 2016

Drug Report, “Avastin- Drug Insights, 2016” highlights the Avastin marketed details, pipeline status and the Global API Manufacturers along with the location. The report covers the Global Market Assessment...

Published:  February 2016
Price:  From

Metastatic Ovarian Cancer-Pipeline Insights, 2016

“ Metastatic Ovarian Cancer-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Metastatic Ovarian Cancer. The report covers the product...

Published:  February 2016
Price:  From

Metastatic Ovarian Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Metastatic Ovarian Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III...

Published:  February 2016
Price:  From

Fallopian Tube Cancer-Pipeline Insights, 2016

“ Fallopian Tube Cancer-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Fallopian Tube Cancer. The report covers the product profiles...

Published:  February 2016
Price:  From

Ovarian Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Ovarian Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline...

Published:  February 2016
Price:  From

Metastatic Ovarian Cancer Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment

“ Metastatic Ovarian Cancer- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014” provides comprehensive insights about phase III pipeline drugs and marketed drugs across...

Published:  February 2016
Price:  From

Ovarian Cancer- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment

“ Ovarian Cancer- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014” provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication....

Published:  February 2016
Price:  From

Metastatic Ovarian Cancer-Pipeline Insights

Summary Metastatic Ovarian Cancer- Pipeline Insights provides the in-depth analysis of the pipeline assets across the Metastatic Ovarian Cancer. The main objective of this report to track competitor...

Published:  February 2016
Price:  From

Epithelial Ovarian Cancer-Pipeline Insights

Summary Epithelial Ovarian Cancer- Pipeline Insights provides the in-depth analysis of the pipeline assets across the Epithelial Ovarian Cancer. The main objective of this report to track competitor...

Published:  February 2016
Price:  From
Loading Indicator

Our Clients